First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.0096 USD -95.56%
Updated: May 3, 2024

Yield10 Bioscience Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yield10 Bioscience Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Operating Expenses
-$14.5m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$19.5B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$12.1B
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$11.6B
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.8B
CAGR 3-Years
-22%
CAGR 5-Years
-19%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.1B
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-20%

See Also

What is Yield10 Bioscience Inc's Operating Expenses?
Operating Expenses
-14.5m USD

Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Operating Expenses amounts to -14.5m USD.

What is Yield10 Bioscience Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
7%

Over the last year, the Operating Expenses growth was -4%. The average annual Operating Expenses growth rates for Yield10 Bioscience Inc have been -12% over the past three years , -8% over the past five years , and 7% over the past ten years .